Who shows the clearest, most measurable benefit?
Physically active people under high physical stress — like athletes training intensely — show the most direct, measurable immune benefit from microbiome interventions. In a 2025 semi-experimental study, 28 male athletes (aged 18–35) who trained at least 3 days a week for 3 years were given either a probiotic or a placebo for 12 weeks [1]. The probiotic group saw a significant increase in monocyte levels both at rest and during exercise, and within that group, lymphocyte, monocyte, and granulocyte percentages rose significantly during activity (p < 0.001). These are frontline immune cells that help fight infection and regulate inflammation. Because intense training can suppress immunity and raise illness risk, this study provides the strongest quantitative evidence here that probiotics can bolster immune resilience in a specific, high-demand population.
Can your gut microbiome predict whether you'll bounce back from trauma?
Yes — and this is where the evidence gets more nuanced and potentially more powerful. A 2022 animal study on rats exposed to traumatic stress (a model for PTSD) found that the gut microbiome before the stress event predicted whether an animal would be resilient or susceptible afterward [3]. Rats that later became susceptible had a pro-inflammatory microbiome at baseline, while those that stayed resilient had an anti-inflammatory microbiome. The susceptible group also had significantly lower levels of key short-chain fatty acids like acetate, valerate, and caproate in their gut, and higher levels of stress hormones (epinephrine and norepinephrine) at baseline. This suggests that microbiome profiling could one day identify people at risk for stress-induced disorders and that targeted microbiome interventions might shift someone from a susceptible to a resilient state. However, this is animal data — the human application is promising but not yet proven.
What about other groups — cancer patients and infants?
The evidence for cancer patients and infants is real but less direct than for athletes or stress-vulnerable individuals. In a 2023 study of 348 colon cancer patients, a specific gut bacterium (Ruminococcus bromii) was linked to better survival, and when combined with a strong immune gene signature, it identified patients with excellent survival odds [2]. This suggests that a healthy microbiome supports anti-tumor immunity, but the study doesn't show that changing the microbiome causes better outcomes — it's an association. For infants, a 2022 study in mice showed that maternal gut bacteria trigger antibodies that are passed through milk to protect newborns from gut infections and shape their developing immune system [4]. A 2025 review also highlights that early-life microbiome-directed therapies could 'imprint lasting immunological effects' [5]. These findings point to early life as a critical window, but the human data is still emerging. Across all groups, the strongest, most actionable evidence today is for physically active adults and those with stress-related vulnerabilities.
About These Sources
This answer is built on 5 peer-reviewed studies — published from 2022 to 2025, 2 from 2024 or later, 2 in Q1 journals, collectively cited 287 times — selected as the most relevant from 6 studies that passed quality screening, drawn from 50 papers retrieved from a database of over 500 million.
Sources used in this answer
Immune Response to Probiotics and Physical Activity: A Clinical Study
In a semi-experimental study of 28 male athletes, 12 weeks of probiotic supplementation significantly increased monocyte levels at rest and during exercise, and raised lymphocyte, monocyte, and granulocyte percentages during activity (p < 0.001), indicating probiotics can counter exercise-induced immune suppression.
An integrated tumor, immune and microbiome atlas of colon cancer
In a cohort study of 348 colon cancer patients, a microbiome signature driven by Ruminococcus bromii was associated with favorable survival, and when combined with an immune gene signature (ICR) into a composite score (mICRoScore), it identified patients with excellent survival probability.
Resilience or susceptibility to traumatic stress: Potential influence of the microbiome
In an animal model of PTSD, rats that were susceptible to traumatic stress had a pro-inflammatory gut microbiome and lower levels of short-chain fatty acids (acetate, valerate, caproate) before stress, while resilient rats had an anti-inflammatory microbiome, suggesting baseline microbiome composition predicts stress resilience.
Maternal gut microbiome–induced IgG regulates neonatal gut microbiome and immunity
In a mouse study, maternal gut microbiome-induced IgG antibodies were transferred to neonates through milk and protected against Citrobacter rodentium infection; IgG-deficient neonates had altered gut microbiomes and increased susceptibility to colitis later in life.
Long-Term Immune Programming through Early-Life Immunotherapies: Risks and Benefits
This 2025 review discusses early-life immunotherapies including microbiome-directed therapies, noting they can imprint lasting immunological effects through epigenetic changes and trained immunity, but also carry risks of immune dysregulation and altered disease susceptibility.